- Wednesday 16 Mar 2022, 15:30 - 16:45
- Spoken Language
- Ticket information
The Faculty Colloquia aim to cover the broad scope of Erasmus School of Philosophy, in analytic and continental philosophy as well as the history of philosophy. Speakers are free in their choice of the subject-matter of their talks, but are requested to present a talk accessible to all philosophers, students notably included.
May we use genetic engineering to help people with a desire to have children? How do we deal with implicit preferences of Artificial Intelligence? What is the role of technology between people? A number of questions that will certainly be addressed in this extraordinary faculty colloquium.
Annelien Bredenoord will be our guest in an extra Faculty Colloquium hosted on the 16th of March. We all know her as the rector magnificus of the Erasmus University, some may know her because of her work in the Dutch Senate, but she also holds the chair Ethics of Technologies at the Erasmus School of Philosophy. To introduce herself to the ESPhil community, she will give a talk on her research in bio ethics.
Traditionally we announce the colloquia with a brief summary, an abstract. This time we present you a snippet of the interview that was held with Annelien Bredenoord on her appointment at ESPhil. We asked her what she would like to speak on.
“Medical ethics, as we know it today, is a modern science. It developed under the influence of emerging technologies in the 1960s. Many people broke from philosophy and theology to engage in the developments in that field. Traditionally, the field was conceived of as a purely philosophical pursuit, where after the so-called empirical turn, novel methodologies could make their appearance. Nowadays, you see a further influence in bioethics from fields like the philosophy of technology, resulting in more participative methods of research. Together with my research group at the University of Utrecht, we have tried to bring that together under what we call Ethical Parallel Research. It’s an approach for the early ethical evaluation of biomedical technologies, such as genome editing. On March 16, I will address the question of how we can conduct new technologies from an early stage by the diverse toolkit of ethics.” – Annelien Bredenoord
The full interview will be published this week.
Annelien Bredenoord is the new Rector Magnificus of EUR from 1 October 2021. She is responsible for education, research and impact, including academic staff (policy), students and science education. Annelien Bredenoord is a professor, member of the Dutch Senate, supervisory authority and director and works at the interface of healthcare, technology and innovation, ethics and politics.
For more information on Annelien Bredenoord, read her EUR profile.